Activity of hydroethanolic extract from Kielmeyera coriacea stems on central nervous system in rats

Acta Scientiarum - Health Sciences

Volumn 26, Issue 2, 2004, Pages 365-368

  Martins, Juliana Vanessa Colombo ^a   Otobone, Fernanda Jacques ^a   Sela, Vania Ramos ^a   Obici, Simoni ^a   Trombelli, Marcos Alberto ^a   Cortez, Diógenes Aparício Garcia ^a   Audi, Elisabeth Aparecida ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Depression; Forced swimming test; Kielmeyera coriacea; Open field; Plus maze test

Indexed keywords

IMIPRAMINE; KILEMEYERA CORIACEA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; FORCED SWIMMING TEST; FREEZE DRYING; GUTTIFERAE; IMMOBILIZATION; KIELMEYERA CORIACEA; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; RAT; SOLVENT EXTRACTION; TRANQUILIZING ACTIVITY;

ANIMALIA; CLUSIACEAE; KIELMEYERA CORIACEA;

EID: 26844551247     PISSN: 16799291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ALVES, T.M.A. et al. Biological screening of Brazilian medicinal plants. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, v. 95, p. 367-373, 2000.
2. BENNET, G.J.; LEE, H. H. Xanthones from Guttiferae. Photochemistry, Kidlington, v. 28, n. 4, p. 967-998, 1989.
3. BORSINE, F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehavior. Rev., Kidlington, v. 19, p. 377-395, 1995.
4. BLIER, B.; DE MONTIGNY, C. Currents advances and trends in the treatment of depression. Trends Pharmacol Sci., Kidlington, v. 15, p. 220-226, 1994.
5. CORTEZ, D.A.G. et al. Xanthones, triterpenes and a biphenyl from Kielnieyera coriacea. Phytochemistry, Kidlington, v. 47, n. 7, p. 1367-1374, 1998.
6. CRUZ, A.P.M. et al. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav., New York, v. 49, n. 1, p. 171-176, 1994.
7. HARKIN, A. et al. Activity and onset of reboxetine and effect of combination with sertraline in an animal model of depression. Eur. J. Pharmacol., Amsterdam., v. 364, p. 123-132, 1999.
8. HYTTEL, J. Pharmacological characterization of selective reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol., London, v. 9, p. 19-26, 1994.
9. JOSEY, E.S.; TACKETT, R.L. St John's wort: a new alternative for depression? Int. Clin. Psychopharmacol., London, v. 37, p. 111-119, 1999.
10. MULLER, W.E. et al. Effects of Hypericum extract in biochemical models of antidepressant activity. Pharmacopsychiatry, Stuttgart, v. 30, n. 2, p. 102-107, 1997.
11. MURUGANANDAM, A.V. et al. The role of Xanthones in the antidepressant activity of Hypericum perforatum involving dopaminergic and serotonergic systems. Biogenic Amines, Sur Yvette, v. 15, n. 5, p. 553-567, 2000.
12. PELLOW, S. et al. Validation of open: enclosed arm entries in elevated plus-maze as a measure of anxiety in rat. J. Neurosci. Meth., Amsterdam v. 14, p. 149-167, 1986.
13. PORSOLT, R.D. et al. Depression: a new animal model sensitive to antidepressant treatments. Nature, London, v. 266, p. 730-732, 1977.
14. PORSOLT, R.D. et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., Amsterdam v. 47, p. 379-391, 1978.
15. ROYCE, J.R. On the construct validity of open-field measures. Psychol. Bull., Washington, DC, v. 84, n. 6, p. 1098-1106, 1977.
16. WASH, R.N.; CUMMINS, R.A. The open-field test: a critical review. Psychol. Bull., Washington, DC, v. 86, p. 482-504, 1976.